This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Onureg : EPAR - Procedural steps taken and scientific information after the auth...
European Medicines Agency’s data protection notice regarding personal data proce...
EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9...
Human medicines European public assessment report (EPAR): Azacitidine Accord, az...
ACT EU workshop on ICH E6 R3 (principles and Annex 1) , Online, European Medicin...
Programme - EMA's Open Door Day
Agenda - ACT EU workshop on ICH E6 (R3)
Template for assessment report for the development of European Union herbal mono...
Agenda of the COMP meeting 18-19 February 2025
Human medicines European public assessment report (EPAR): Cibinqo, abrocitinib, ...
Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Va...
Human medicines European public assessment report (EPAR): Daptomycin Hospira, da...
Human medicines European public assessment report (EPAR): Ulunar Breezhaler, ind...
Minutes - HMA-EMA joint Big Data Steering Group teleconference - 11 December 2024
International Coalition of Medicines Regulatory Authorities (ICMRA)
Contact details of national competent authorities for requests of translation ex...